Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
about
Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensSynthetic Nanoparticles for Vaccines and ImmunotherapyImmunological properties of gold nanoparticlesPhenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in MiceDeciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.Adjuvants in micro- to nanoscale: current state and future direction.Gold nanoparticles and vaccine development.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development.Recent Advances in Burkholderia mallei and B. pseudomallei Research.The Use of Reverse Vaccinology in the Design and Construction of Nano-glycoconjugate Vaccines against Burkholderia pseudomallei.A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates.Quantification of regional aerosol deposition patterns as a function of aerodynamic particle size in rhesus macaques using PET/CT imaging.Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.Vaccines for the Prevention of Melioidosis and Glanders.
P2860
Q27011190-508A1470-945C-4121-B3FE-E5DF8F6E40E3Q28085375-7BC38D3B-DE85-41C8-A900-07997495F89BQ33578950-C0FE867A-5797-4462-B988-FF052D19EFA4Q36620684-B3213702-2AFC-4990-88FA-0F0E6C25C75FQ38287677-158E3C6D-27FC-4A11-A463-488935B13AD9Q38520210-93F77226-D7E4-416E-B502-DF15E53E3C9FQ38543673-81E2BF9D-4C84-4908-98BC-B91474642276Q38680785-02223EA1-13BE-4CBE-9540-7E1631F2AABEQ38784773-007BB476-891D-43C4-B3CF-9FD20A42B017Q38890754-152C0B12-AB3A-489A-8A9D-BC8F36852E2FQ39012279-98666D09-A6DF-4105-848A-BD9F82963C41Q39197667-112E9E13-E124-45EC-A5A7-21FB25439E45Q39970602-56AFAB02-DB6A-474D-B593-02C7E51A2317Q40048191-E04B70CB-80C2-40A7-9238-FF5B65F21C16Q46242885-EF6F7EA8-C3FD-4B26-8265-3CCF4D50E5D6Q47174320-84822474-4E0D-473A-A4AC-9C4303188A11Q48270562-0B8C4B95-6ED2-4DFF-8C03-5FA825E3E0A8Q49834322-250CF6F0-C3CE-4176-88C7-79AF7A3099D3
P2860
Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@ast
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@en
type
label
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@ast
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@en
prefLabel
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@ast
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@en
P2093
P2860
P50
P1433
P1476
Protection of non-human primat ...... rticle glycoconjugate vaccine.
@en
P2093
Christopher L Hatcher
Heather Vinet-Oliphant
Lisa A Morici
Richard W Titball
P2860
P304
P356
10.1016/J.VACCINE.2014.11.057
P407
P577
2014-12-19T00:00:00Z